Möten och konferenser

konferens

Nationell konferens om kliniska studier

7-8 September 2017, Stockholm

Den nationella konferensen om kliniska studier är en årlig mötesplats för kunskapsutbyte och nätverkande som riktar sig till personal inom akademi, hälso- och sjukvård och industri.

Hur ser framtidens forskningsmetoder ut? Vilken roll har framtidens forskningspatient och inom vilka terapiområden bedrivs framtidens kliniska studier? Dessa är några av de frågor som tas upp under konferensen med temat ”Framtidens kliniska studier”.
Nationell konferens om kliniska studier arrangeras av den nationella satsningen Kliniska Studier Sverige, som är ett samarbete mellan Vetenskapsrådet och Sveriges sex sjukvårdsregioner. Karolinska Trial Alliance (KTA) är 2017 års regionala värd.

När: den 7–8 september
Var: Aula Medica, Stockholm 

Här hittar du mer information om konferensen http://www.kliniskastudier.se/nationell-konferens-om-kliniska-studier.html





konferens

Nordic Conference on Pragmatic Clinical Studies

12-13 December 2017, Uppsala

Too many decisions about health and healthcare are still not supported by high quality evidence.  Prospectively designed registries, cohort studies and randomized clinical trials conducted in the context of clinical practice - pragmatic clinical trials – may be highly valuable as source of knowledge in the future.
The purpose of this conference is to evaluate opportunities and challenges with pragmatic clinical studies and provide outstanding examples of research cooperation and initiatives in the Nordic countries for the advancement of pragmatic clinical studies into healthcare practices. In addition to provide practical aspects of designing and running pragmatic trials.
The conference comprises three main themes over two full days meeting:
•Pragmatic clinical studies in the context of healthcare and registries
•Regulatory challenges to pragmatic clinical studies in the Nordic countries
•From epidemiology to healthcare – pitfalls and possibilities

Discuss with leaders from healthcare, academia, pharma and med-tech industry, and regulatory authorities. How do we assure quality in pragmatic trials, including registry-based randomized clinical trials and cluster-randomized clinical trials? Will the new EU regulation affect possibilities to perform pragmatic clinical trials in the Nordic countries? Find out what roles patient advocacy groups and funding organizations play in advocating new pragmatic trial approaches.

More information: http://www.trippus.se/web/presentation/web.aspx?evid=0jxWXsxZBkQAeR1dFysR8Q==&ecid=nH0mTWFZMZz4PFNJMMeH1w==&ln=eng&emid=90vkbAWImBiJ+UKzNOASUQ==&view=infopage&template=desktop


Kontakta Forum Uppsala-Örebro: info-fuo@ucr.uu.se